A focused Research & Development Powerhouse

Research Areas & Focus

For Remedica, the mission is clear: to develop and deliver transformative products that can change lives on a global scale. To accomplish this, we seize every opportunity that emerges from the rapid advancement of science and technology.

We operate as a focused Research and Development (R&D) powerhouse, meticulously crafting scientific formulations and manufacturing processes into invaluable treatments and robust solutions for a multitude of global markets.

The company channels its R&D prowess into the creation of new generic and “generic plus” pharmaceutical products. Our R&D team thrives on generating innovative concepts, aligning them with market needs and harnessing synergies across various therapeutic domains.  

Remedica has been investing recently in the development of new pharmaceutical offerings. This approach has not only broadened our product portfolio but has also resulted in international patents protecting our innovative concepts.

Beyond serving our agents, we share this technology with global partners through licensing and supply agreements, expanding our reach into new markets and widening our customer base. Simultaneously, our R&D team maintains a relentless focus on enhancing and upgrading our existing product offerings. 

Remedica’s R&D department operates with specialised functional teams, each contributing to the development of pharmaceutical products with the highest levels of safety, efficacy and quality. These tasks encompass everything from formulation and process development to analytical method development and validation and the scaling up to production. Stability studies of our products are conducted under various climatic conditions to establish their shelf-life.

Furthermore, every R&D project benefits from vigilant monitoring and management by a dedicated team of project managers, ensuring that projects adhere to agreed-upon timelines and deliverables while maintaining the highest standards of product quality.

Clinical Trials

Generic or “Generic Plus” products undergo clinical trials in the form of pharmacokinetic studies on human subjects in order to demonstrate therapeutic equivalence.

The company’s Clinical Operations Department has demonstrated a record in the selection of accredited Clinical Research Organizations (CROs).

The department also excels in designing, planning, and executing clinical trials to demonstrate bioequivalence of the generic drug to the branded counterpart in addition to ensuring compliance with regulatory requirements including compliance with Good Clinical Practice (GCP) through audits of CROs and respective clinical trials.

Focused on Excellence

Research Areas & Focus

Clinical Trials

Explore our Global Reach and strategic Expansion